Albany, NY -- (SBWIRE) -- 02/21/2019 -- Next-generation drug-eluting stent market is primarily driven by elevating a number of geriatric population on the global level as they are at high risk of developing arterial disorders. In addition, increasing prevalence and incidence of atherosclerosis pertaining to unhealthy lifestyle and obesity are also driving the growth of the next-generation drug eluting stents market. For instance, according to the research conducted, more than 15.8 million individual is suffering from coronary artery disease, and approximately 8 million of them have has heart attack. However, factors such as reduction in the drug-eluting stents pricing, and availability of alternative therapy procedure are the major obstacle to the market growth of next-generation drug eluting stent. Increasing preference for drugs over the surgical procedure of stent implants and increased risk of developing late-stage thrombosis are limiting the growth of next-generation drug-eluting stent market.
The global next generation drug eluting stent market can be segmented on the basis of polymer type, material type, end-user, and region.
On the basis of polymer type, global next generation drug eluting stent market can be segmented as:
- Durable Polymer
- Bioabsorbable Polymer
On the basis of material type, global next generation drug eluting stent market can be segmented as:
- Cobalt chromium
- Stainless Steel
For More Info, Get Sample Report Here: https://www.marketresearchreports.biz/sample/sample/11795
On the basis of end user, global next generation drug eluting stent market can be segmented as:
- Ambulatory surgical Centers
On the basis of region, global next generation drug eluting stent market can be segmented as:
- North America
- Latin America
- Asia Pacific
- Middle East and Africa
Next-generation drug-eluting stent is a modification of previous developed drug-eluting stent which offers enhanced drug delivery and stent flexibility. The key alteration includes utilization of bioabsorbable polymer and polymer-free drug delivery from stents offers enhancement in terms of safety, drug efficacy, and longer usability. Since the introduction of drug-eluting stents, various technological advancement has been witnessed to generate a product offering accurate delivery of drug and safety concerns.
Geographically, global next-generation drug-eluting stent market can be segmented into North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.
Some of the market participants in the global next generation drug eluting stent market are Abbott Laboratories, Biosensors International Group, Ltd., Medtronic plc, Sorin Group, SMT, and Terumo Corporation.
Get Complete TOC and List of Figures of the Report at: https://www.marketresearchreports.biz/sample/toc/11795
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
- Tailwinds and headwinds molding the market's trajectory
- Market segments based on products, technology, and applications
- Prospects of each segment
- Overall current and possible future size of the market
- Growth pace of the market
- Competitive landscape and key players' strategies
The main aim of the report is to:
- Enable key stakeholder's in the market bet right on it
- Understand the opportunities and pitfalls awaiting them
- Assess the overall growth scope in the near term
- Strategize effectively with respect to production and distribution
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.
View Complete Report at: https://www.marketresearchreports.biz/pharmaceuticals-healthcare-and-medical-devices/11795/next-generation-drug-eluting-stent-global-market-research-reports
MarketResearchReports.biz is a seller of syndicated market studies, featuring an exhaustive collection of research reports from leading international publishers. Our repository is diverse, spanning virtually every industrial sector and even more every category and sub-category within the industry. We also provide consulting services to enable our clients have a dynamic business perspective.
90 State Street, Suite 700
Albany, NY 12207
Toll Free: 866-997-4948 (USA-Canada)